Search Results - "VAN DER MEER, Pieter"

Transfusion reactions after transfusion of platelets stored in PAS‐B, PAS‐C, or plasma: a nationwide comparison by van Hout, Fabienne M.A., van der Meer, Pieter F., Wiersum‐Osselton, Johanna C., Middelburg, Rutger A., Schipperus, Martin R., van der Bom, Johanna G., Kerkhoffs, Jean‐Louis

“…BACKGROUND Platelets (PLTs) stored in PLT additive solution (PAS) are associated with fewer allergic reactions than plasma‐stored PLTs. However, earlier…”
Get full text

The quality of red cells stored under blood bank conditions: Is donor age just a number? by Meer, Pieter F., Klei, Thomas R. L.

Get full text

Dirk de Korte (1955–2024) by Meer, Pieter F., Lagerberg, Johan, Klei, Thomas R. L.

Get full text

Storage properties of platelet concentrates from umbilical cord blood prepared using three different methods by Cortesi, Valeria, Lopriore, Enrico, Cavallaro, Giacomo, Bontekoe, Ido J., Meer, Pieter F., Fustolo‐Gunnink, Susanna, Raffaeli, Genny, Ghirardello, Stefano, Klei, Thomas R. L.

“…Background Thrombocytopenia, common in preterm newborns, may increase bleeding risk and is often treated with transfusions. Recent studies reveal that…”
Get full text

Revisiting study design and methodology for pathogen reduced platelet transfusions: a round table discussion by Heddle, Nancy M., Cardoso, Marcia, Meer, Pieter F.

“…Pathogen inactivation/reduction technologies for platelet components have been developed to enhance microbial safety, and many studies have been carried out to…”
Get full text

A crosswalk tabular review on methods and outcomes from randomized clinical trials using pathogen reduced platelets by Rebulla, Paolo, Garban, Frederic, Meer, Pieter F., Heddle, Nancy M., McCullough, Jeffrey

Get full text

Exploring the components of bleeding outcomes in transfusion trials for patients with hematologic malignancy by Balitsky, Amaris K., Liu, Yang, Van der Meer, Pieter F., Heddle, Nancy M., Arnold, Donald M.

“…Background Clinically significant bleeding in patients with hematologic malignancies is a heterogeneous composite outcome currently defined as World Health…”
Get full text

Allogeneic and autologous serum eye drops: a pilot double‐blind randomized crossover trial by van der Meer, Pieter F., Verbakel, Sanne K., Honohan, Áine, Lorinser, Jos, Thurlings, Rogier M., Jacobs, Joannes F.M., de Korte, Dirk, Eggink, Catharina A.

“…Purpose Serum eye drops (SEDs) are used to treat a variety of ocular surface defects. Serum eye drops (SEDs) are normally produced from the patient’s blood…”
Get full text

Effect of aspirin intake at bedtime versus on awakening on circadian rhythm of platelet reactivity. A randomised cross-over trial by Bonten, T N, Saris, A, van Oostrom, M J, Snoep, J D, Rosendaal, F R, Zwaginga, J, Eikenboom, J, van der Meer, P F, van der Bom, J G

“…The risk of acute cardiovascular events is highest during morning hours, and platelet activity peaks during morning hours. The effect of timing of aspirin…”
Get more information

The effect of near-infrared low-level light on the in vitro quality of platelets during storage by Bontekoe, Ido J, van der Meer, Pieter F, de Laleijne-Liefting, Lara A E, Klei, Thomas R L

“…Near-infrared (NIR) light has been successfully applied to improve the quality of mouse platelets during storage. Because it is suspected that the mitochondria…”
Get full text

Thromboelastography as a tool to evaluate blood of healthy volunteers and blood component quality: a review by Bontekoe, Ido J., van der Meer, Pieter F., Korte, Dirk

“…Thromboelastography is a technique to evaluate the overall coagulation behaviour of blood and blood components. First, we evaluated the literature concerning…”
Get full text

Platelet storage performance is consistent by donor: a pilot study comparing “good” and “poor” storing platelets by Bontekoe, Ido J., van der Meer, Pieter F., van den Hurk, Katja, Verhoeven, Arthur J., de Korte, Dirk

“…BACKGROUND In retrospective studies, it has been shown that differences in storage variables of platelet (PLT) concentrates (PCs) are partially donor…”
Get full text

Donor variation in stored platelets: Higher metabolic rates of platelets are associated with mean platelet volume, activation and donor health by Bontekoe, Ido J., Meer, Pieter F., Tanis, Bea C., Korte, Dirk, Verhoeven, Arthur J., Raat, Nicolaas J. H., Specht, Patricia A. C., Mik, Egbert G., Klei, Thomas R. L.

“…Background Platelets (PLTs) differ in glycolytic activity, resulting in rapid acidification of ‘poor’ storing PLT concentrates (PCs) in plasma, or depletion of…”
Get full text

The role of pathogen‐reduced platelet transfusions on HLA alloimmunization in hemato‐oncological patients by Saris, Anno, Kerkhoffs, Jean Louis, Norris, Philip J., Ham, S. Marieke, Brinke, Anja, Brand, Anneke, Meer, Pieter F., Zwaginga, Jaap Jan

“…BACKGROUND Platelet transfusions can induce alloimmunization against HLA antigens. The use of pathogen‐reduced platelet concentrates (PCs) was suggested to…”
Get full text

Efficacy and safety of platelet additive solution‐E stored platelet concentrates by Spelmink, Saskia E., Jager, Suzanne T., Watering, Leo, Meer, Pieter F., Gammeren, Adriaan J., Wiersum‐Osselton, Johanna C., Klei, Thomas R. L., Kerkhoffs, Jean‐Louis H.

“…Introduction In 2018, platelet (PLT) additive solution‐E (PAS‐E) was introduced. The implementation of PAS‐E was expected to diminish the number of allergic…”
Get full text

Altered Fc glycosylation of anti‐HLA alloantibodies in hemato‐oncological patients receiving platelet transfusions by Osch, Thijs L. J., Pongracz, Tamas, Geerdes, Dionne M., Mok, Juk Yee, Esch, Wim J. E., Voorberg, Jan, Kapur, Rick, Porcelijn, Leendert, Kerkhoffs, Jean‐Louis H., Meer, Pieter F., Schoot, C. Ellen, Haas, Masja, Wuhrer, Manfred, Vidarsson, Gestur

“…Background The formation of alloantibodies directed against class I human leukocyte antigens (HLA) continues to be a clinically challenging complication after…”
Get full text

Volume-reduced platelet concentrates: optimization of production and storage conditions by van der Meer, Pieter F., Bontekoe, Ido J., Kruit, Guido, Peeters, Geert, van Toledo, Pleun J., Tomson, Bert, de Korte, Dirk

“…BACKGROUND: Plasma can be removed from platelet (PLT) concentrates (PCs) when volume reduction for PLT transfusion is indicated. Volume‐reduced PCs are…”
Get full text

The history of buffy coat platelet concentrates: The Dutch story by Meer, Pieter F., Reesink, Hendrik W., Korte, Dirk, Loos, Johannes A., Klei, Thomas R. L.

“…The buffy coat method as a source for platelet concentrates was developed in the 1970s and is still used in many blood centres around the world. Development of…”
Get full text

Platelet storage properties are associated with donor age: in vitro quality of platelets from young donors and older donors with and without Type 2 diabetes by Bontekoe, Ido J., Meer, Pieter F., Verhoeven, Arthur J., Korte, Dirk

“…Background and Objectives Previously it has been shown that platelet (PLT) storage performance is consistent by donor. Differences involved metabolic activity,…”
Get full text

The association between haemorrhage and markers of endothelial insufficiency and inflammation in patients with hypoproliferative thrombocytopenia: a cohort study by Ypma, Paula F., Geloven, Nan, Kerkhoffs, Jean Louis H., Boekhorst, Peter, Zwaginga, Jaap J., Beckers, Erik A. M., Brand, Anneke, Meer, Pieter F., Eikenboom, Jeroen C. J.

“…Summary In daily haematological practice, predicting bleeding in thrombocytopenic patients is difficult, and clinicians adhere to transfusion triggers to guide…”
Get full text